Innovative Technologies to Effectively Treat Multi-Drug Resistant and/or Biofilm-Embedded Bacteria
Innovative Surface Technologies, Inc., Minnesota, United States
The technology prototype is a medicated wound dressing formulation containing a novel drug combination effective against common multi-drug resistant wound pathogens. The technology combines several desirable characteristics including nanofibrillar barrier, hemostatic activity, antibiofilm efficacy, and controlled release.
Primary Application Area: Pharmaceuticals & Personal Care
Technology Development Status: Prototype
Technology Readiness Level: TRL 6
FIGURES OF MERIT
Value Proposition: 1) Prevention of MDR skin infections: hospitals are financially incentivized to prevent nosocomial skin infections such as SSI. Average cost per infected patient ranges from $11,874 - $34,670, higher for MDR infections.
Organization Type: Commercial Startup (C+)
Showcase Booth #: 422
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date: Phase I SBIR NIH/NIGM R43GM093398 $172,763
Primary Sources of Funding: Personal Savings, Federal Grant
Looking for: Both Funding and Development Partners